Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I crossover pharmacokinetic study of three intranasal testosterone gel formulations in healthy adult men
NL-OMON36048Phase 1Active, not recruiting
- Sponsor
- Trimel Pharmaceuticals
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of testosterone in Hypoandrogenism (TD) (3 arms), sponsored by Trimel Pharmaceuticals. Primary endpoints: Testosterone Cmin over 12 hours, Testosterone Cmax over 12 hours and 4 more. Started Jun 2011; status: active, not recruiting.
02
Drugs
testosterone
03
Conditions
Hypoandrogenism (TD)
Beyond the preview
Go deeper on NL-OMON36048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36048.